Cash dropped to NZ$2.3m as operating burn nearly doubled to NZ$3.7m

What changed

Reported revenue (disclosed as "other income") rose 34.1% to NZ$0.4m from NZ$0.3m, but remains immaterial — Rua is still pre-commercial, with management framing the period as "first revenue imminent". The operating loss widened: PBT deteriorated 8.0% to a NZ$3.5m loss and NPAT worsened 5.6% to a NZ$2.5m loss, with the narrower NPAT gap reflecting a larger tax credit rather than better operations. Operating cash outflow nearly doubled to NZ$3.7m from NZ$2.0m, while capex fell to NZ$0.3m from NZ$1.1m. Cash on hand fell 88.2% to NZ$2.3m from NZ$19.2m; borrowings were fully repaid (nil vs NZ$32k), and equity declined 14.3% to NZ$26.5m.

What matters

• Runway is the dominant issue. Half-year operating burn of NZ$3.7m plus NZ$0.3m capex produced a pre-lease FCF outflow of NZ$4.0m against a closing cash balance of NZ$2.3m. At current burn, the business will need additional funding or a rapid revenue ramp before the next full-year print.
• Losses are widening while spend is concentrating. Capex stepped down (NZ$0.3m vs NZ$1.1m), yet operating cash burn still rose ~89% — the cost base absorbing revenue build-out is expanding faster than the top line.
• PBT is the cleaner read. The effective tax benefit of 29.1% (HY22) vs 27.6% (HY21) flatters NPAT; PBT deterioration of 8.0% is the better operating signal.

Expectations

No quantified guidance, forward-work balance, or stated targets were disclosed. The FY21 shape shows HY21 was first-half-weighted (59.6% of full-year revenue, 52.8% of full-year loss), but that pattern is reading noise given the trivial revenue base — the FY21 "revenue" figure itself is under NZ$0.5m. Annualising the current half does not produce a meaningful forward indicator while the product-revenue engine is not yet running. The release supports the claim that commercialisation activity progressed; it does not support any view on scale or timing of material revenue.

Quality of result

Low quality on every lens that applies at this stage. Revenue is "other income", not product sales. The operating loss widened despite a larger reported revenue number. Cash conversion cannot be benchmarked because EBITDA was not disclosed, but operating cash outflow (NZ$3.7m) was substantially larger than the NPAT loss (NZ$2.5m), indicating non-cash add-backs are not cushioning the burn. Lower capex helped reported investing flows but did not offset the widening operating outflow. Working capital cannot be unpacked — only inventory (NZ$83.5k) was separately disclosed. There is no timing or balance-sheet tailwind flattering this result; it is a genuine step-up in cash consumption.

Unresolved

• When, and at what scale, does product revenue actually arrive? The release says "imminent" but provides no volume, pricing, or contract-value data.
• How does the board intend to bridge the gap between a NZ$2.3m cash balance and a >NZ$7m annualised operating burn — further capital raise, debt, or accelerated revenue?
• What is the committed cost base going into H2, given capex dropped sharply but opex-driven burn rose?
• No segment, customer concentration, or forward-work disclosure was provided to stress-test the commercialisation narrative.

This briefing cannot assess Rua's funding plans, pipeline pricing, or probability of securing the imminent first revenues referenced by management, as none of that detail was supplied in the release.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.